Goldman Sachs’s Immunovant IMVT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $19.1M | Buy |
|
|||||
|
2025
Q1 | $17.2M | Buy |
|
|||||
|
2024
Q4 | $16.8M | Buy |
|
|||||
|
2024
Q3 | $14.9M | Buy |
|
|||||
|
2024
Q2 | $10.9M | Buy |
|
|||||
|
2024
Q1 | $11.3M | Sell |
|
|||||
|
2023
Q4 | $19.3M | Sell |
|
|||||
|
2023
Q3 | $19.6M | Buy |
|
|||||
|
2023
Q2 | $6.17M | Sell |
|
|||||
|
2023
Q1 | $6.84M | Buy |
|
|||||
|
2022
Q4 | $6.59M | Buy |
|
|||||
|
2022
Q3 | $396K | Sell |
|
|||||
|
2022
Q2 | $955K | Sell |
|
|||||
|
2022
Q1 | $1.96M | Buy |
|
|||||
|
2021
Q4 | $2.5M | Sell |
|
|||||
|
2021
Q3 | $3.99M | Buy |
|
|||||
|
2021
Q2 | $2.17M | Sell |
|
|||||
|
2021
Q1 | $16.8M | Buy |
|
|||||
|
2020
Q4 | $36.3M | Buy |
|
|||||
|
2020
Q3 | $4.34M | Sell |
|
|||||
|
2020
Q2 | $3.67M | Buy |
|
|||||
|
2020
Q1 | $1.15M | Buy |
|